INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / IBD BREAKOUT
Total 13F shares
7,342
Share change
-24,629
Total reported value
$237,089
Price per share
$32.26
Number of holders
7
Value change
-$764,394
Number of buys
2
Number of sells
2

Institutional Holders of INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) as of Q2 2023

As of 30 Jun 2023, INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,342 shares. The largest 7 holders included OSAIC HOLDINGS, INC., UBS Group AG, Asset Dedication, LLC, BENJAMIN F. EDWARDS & COMPANY, INC., HOLLENCREST CAPITAL MANAGEMENT, CWM, LLC, and AdvisorNet Financial, Inc. This page lists 7 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.